These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32807683)

  • 21. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
    Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F
    Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New autoantibody mediated disorders of the central nervous system.
    Lang B; Dale RC; Vincent A
    Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult-onset temporal lobe epilepsy suspicious for autoimmune pathogenesis: Autoantibody prevalence and clinical correlates.
    Kuehn JC; Meschede C; Helmstaedter C; Surges R; von Wrede R; Hattingen E; Vatter H; Elger CE; Schoch S; Becker AJ; Pitsch J
    PLoS One; 2020; 15(10):e0241289. PubMed ID: 33119692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
    Hachiya Y; Miyata R; Tanuma N; Hongou K; Tanaka K; Shimoda K; Kanda S; Hoshino A; Hanafusa Y; Kumada S; Kurihara E; Hayashi M
    Brain Dev; 2013 Aug; 35(7):670-4. PubMed ID: 23142103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of autoantibodies to neural antigens in the CSF of Japanese encephalitis patients and correlation of findings with the outcome.
    Desai A; Ravi V; Guru SC; Shankar SK; Kaliaperumal VG; Chandramuki A; Gourie-Devi M
    J Neurol Sci; 1994 Mar; 122(1):109-16. PubMed ID: 7515105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
    Endres D; von Zedtwitz K; Matteit I; Bünger I; Foverskov-Rasmussen H; Runge K; Feige B; Schlump A; Maier S; Nickel K; Berger B; Schiele MA; Cunningham JL; Domschke K; Prüss H; Tebartz van Elst L
    Biol Psychiatry; 2022 Aug; 92(4):261-274. PubMed ID: 35606187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System.
    van Coevorden-Hameete MH; Titulaer MJ; Schreurs MW; de Graaff E; Sillevis Smitt PA; Hoogenraad CC
    Front Mol Neurosci; 2016; 9():37. PubMed ID: 27303263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
    Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
    PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diagnostic approach for identifying anti-neuronal antibodies in children with suspected autoimmune encephalitis.
    Nakahara E; Sakuma H; Kimura-Kuroda J; Shimizu T; Okumura A; Hayashi M
    J Neuroimmunol; 2015 Aug; 285():150-5. PubMed ID: 26198933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal central nervous system syndromes probably mediated by autoantibodies.
    Chefdeville A; Honnorat J; Hampe CS; Desestret V
    Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.
    Fukuyama T; Takahashi Y; Kubota Y; Mogami Y; Imai K; Kondo Y; Sakuma H; Tominaga K; Oguni H; Nishimura S
    Epilepsy Res; 2015 Jul; 113():34-43. PubMed ID: 25986190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
    Finke C; Bartels F; Lütt A; Prüss H; Harms L
    J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation of anti-N-methyl-d-aspartate receptor and anti-voltage-gated potassium channel complex antibodies in children: A series of 24 cases.
    Konuskan B; Yildirim M; Topaloglu H; Erol I; Oztoprak U; Tan H; Gocmen R; Anlar B
    Eur J Paediatr Neurol; 2018 Jan; 22(1):135-142. PubMed ID: 29153996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
    Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
    Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
    Dale RC; Church AJ; Surtees RA; Lees AJ; Adcock JE; Harding B; Neville BG; Giovannoni G
    Brain; 2004 Jan; 127(Pt 1):21-33. PubMed ID: 14570817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
    Scotton WJ; Karim A; Jacob S
    Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors.
    Liao S; Li C; Bi X; Guo H; Qian Y; Liu X; Miao S; Hu H; Cao B
    J Neuroinflammation; 2021 Dec; 18(1):282. PubMed ID: 34872566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
    Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
    Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.